Clinical trial

Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD

NCT04521452

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Evogliptin Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-09-01

PhasePHASE4

Conditions

CAVDunresolved

Interventions

EvogliptinDRUG

Sponsors & collaborators

Asan Medical Centerlead sponsor

REDNVIA Co., Ltd.collaborator

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04521452 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.